DRUGMAKERS GlaxoSmithKline and Eli Lilly posted weaker than expected quarterly revenue, continuing an industry theme and underscoring challenges from price cuts and a lack of new products.

American stocks slipped today as investors awaited the US Labor Department’s jobs report and reacted to Yahoo Inc.’s announcement of its biggest management shake-up in more than five years.